THE HYPOTHESES OF DIFFERENT DOPAMINE RECEPTOR MECHANISMSCOSTALL B; NAYLOR RJ.1981; LIFE SCI. (1973); ISSN 0024-3205; GBR; DA. 1981; VOL. 28; NO 3; PP. 215-229; BIBL. 112 REF.Article

INTERACTION OF THE PUTATIVE DOPAMINE AUTORECEPTOR AGONISTS 3-PPP AND TL-99 WITH (³H) APOMORPHINE BINDING SITES IN RAT STRIATAL MEMBRANESWILLIAMS M; TOTARO JA.1982; EUROPEAN JOURNAL OF PHARMACOLOGY; ISSN 0014-2999; NLD; DA. 1982; VOL. 86; NO 1; PP. 35-42; BIBL. 31 REF.Article

DOPAMINE RECEPTOR PROFILE OF CO-DERGOCRINE (HYDERGINEREG.) AND ITS COMPONETSMARKSTEIN R.1982; EUROPEAN JOURNAL OF PHARMACOLOGY; ISSN 0014-2999; NLD; DA. 1982; VOL. 86; NO 2; PP. 145-155; BIBL. 20 REF.Article

EVIDENCE FOR THE PRESENCE OF D₂ AND 5-HT₂ RECEPTORS IN THE HUMAN PREFONTAL CORTEXMITA T; KUNO T; NAKAI H et al.1982; JAPANESE JOURNAL OF PHARMACOLOGY; ISSN 0021-5198; JPN; DA. 1982; VOL. 32; NO 6; PP. 1027-1032; BIBL. 24 REF.Article

THE COMPETITIVE INHIBITION OF GLUCOSE TRANSPORT IN HUMAN ERYTHROCYTES BY COMPOUNDS OF DIFFERENT STRUCTURESLACKO L; WITTKE B.1982; BIOCHEMICAL PHARMACOLOGY; ISSN 0006-2952; GBR; DA. 1982; VOL. 31; NO 10; PP. 1925-1929; BIBL. 11 REF.Article

DIFFERENTIAL BLOCKING EFFECTS OF SEVERAL DOPAMINE RECEPTOR ANTAGONISTS FOR PERIPHERAL PRE- AND POSTSYNAPTIC DOPAMINE RECEPTORS IN THE ANESTHETIZED DOGSHEPPERSON NB; DUVAL N; MASSINGHAM R et al.1982; JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS; ISSN 0022-3565; USA; DA. 1982; VOL. 221; NO 3; PP. 753-761; BIBL. 27 REF.Article

DOPAMINERGIC MECHAISMS IN THIOPHENE-2-ALDOXIME TREMORKURKJIAN R; BANNA NR.1982; EXPERIENTIA; ISSN 0014-4754; CHE; DA. 1982; VOL. 38; NO 7; PP. 841-842; BIBL. 6 REF.Article

ACTIVATION BY REDUCED GLUTATHIONE OF METHOTREXATE TRANSPORT INTO ISOLATED RAT LIVER CELLSLESZCYNSKA A; PFAFF E.1982; BIOCHEMICAL PHARMACOLOGY; ISSN 0006-2952; GBR; DA. 1982; VOL. 31; NO 10; PP. 1911-1918; BIBL. 23 REF.Article

POSSIBLE DA AGONIST PROPERTIES OF NALOXONEFEIGENBAUM J; YANAI J; BLASS R et al.1982; INTERNATIONAL JOURNAL OF NEUROSCIENCE; ISSN 0020-7454; GBR; DA. 1982; VOL. 17; NO 3; PP. 139-144; BIBL. 2 P.Article

BRAIN DOPAMINE RECEPTORSSEEMAN P.1980; PHARMACOL. REV.; ISSN 0031-6997; USA; DA. 1980; VOL. 32; NO 3; 58 P.; BIBL. 1278 REF.Serial Issue

STRIATAL BINDING OF 2-AMINO-6,7-(³H) DIHYDROXY-1,2,3,4-TETRAHYDRONAPHTHALENE TO TWO DOPAMINERGIC SITES DISTINGUISHED BY THEIR LOW AND HIGH AFFINITY FOR NEUROLEPTICSLIST SJ; WREGGETT KA; SEEMAN P et al.1982; J. NEUROSCI.; ISSN 0270-6474; USA; DA. 1982; VOL. 2; NO 7; PP. 895-906; BIBL. 2 P.Article

EFFECT OF APOMORPHINE ON SCHIZOPHRENIC SYMPTOMS.SMITH RC; TAMMINGA C; DAVIS JM et al.1977; J. NEUR. TRANSM.; AUSTR.; DA. 1977; VOL. 40; NO 2; PP. 171-176; BIBL. 16 REF.Article

DIFFERENTIAL SENSITIVITY TO AMPHETAMINE FOLLOWING LONG-TERM TREATMENT WITH CLOZAPINE OR HALOPERIDOLREBEC GV; PEIRSON EE; MCPHERSON FA et al.1982; PSYCHOPHARMACOLOGIA; ISSN 0033-3158; DEU; DA. 1982; VOL. 77; NO 4; PP. 360-366; BIBL. 30 REF.Article

ROLE OF STRIATAL DOPAMINERGIC RECEPTORS IN AMPHETAMINE-INDUCED BEHAVIORAL FACILITATIONCONWAY PG; URETSKY NJ.1982; JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS; ISSN 0022-3565; USA; DA. 1982; VOL. 221; NO 3; PP. 650-655; BIBL. 37 REF.Article

PERSISTENT MODIFICATION OF DOPAMINE RECEPTOR DEVELOPMENTFRIEDHOFF AJ.1980; DEV. IN NEUROSCI.; NLD; DA. 1980; VOL. 9; PP. 231-232; BIBL. 6 REF.Conference Paper

LSD LABELS A NOVEL DOPAMINE RECEPTOR IN MOLLUSCAN NERVOUS SYSTEM.DRUMMOND AH; BUCHER F; LEVITAN IB et al.1978; NATURE; G.B.; DA. 1978; VOL. 272; NO 5651; PP. 368-370; BIBL. 17 REF.Article

THERMODYNAMIC DIFFERENCES BETWEEN AGONIST AND ANTAGONIST INTERACTIONS WITH BINDING SITES FOR (^U3H)SPIROPERIDOL IN RAT STRIATUMZAHNISER NR; MOLINOFF PB.1983; MOLECULAR PHARMACOLOGY; ISSN 0026-895X; USA; DA. 1983; VOL. 23; NO 2; PP. 303-309; BIBL. 26 REF.Article

A BEHAVIOURAL STUDY OF THE CHANGES IN THE CENTRAL NERVOUS SYSTEM OF MICE AFTER SUBCHRONIC TREATMENT WITH THE SELECTIVE DOPAMINE AUTORECEPTOR AGONIST 3-PPP(DL-3-(3-HYDROXYPHENYL)-N-N-PROPYLPIPERIDINE)JACKSON D; CARLSSON A; HJORTH S et al.1982; J. NEURAL TRANSM.; ISSN 0300-9564; AUT; DA. 1982; VOL. 53; NO 4; PP. 233-245; BIBL. 3 P.Article

MONOAMINERGIC MECHANISMS IN STRESS-INDUCED ANALGESIAJENSEN TS; SMITH DF.1982; J. NEURAL TRANSM.; ISSN 0300-9564; AUT; DA. 1982; VOL. 53; NO 4; PP. 247-255; BIBL. 3 P.Article

RECEPTORS OF DOPAMINE ANTAGONISTS. NEW BIOCHEMICAL APPROACHES, JANSEN PHARMACEUTICA, BEERSE BELGIUM. JALY 6-8, 19781978; LIFE SCI.; GBR; DA. 1978; VOL. 23; NO 17-18; PP. 1745-1879; BIBL. DISSEM.Article

TREATMENT OF HUNTINGTON'S CHOREA WITH BROMOCRIPTINE.FRATTOLA L; ALBIZZATI MG; SPANO PF et al.1977; ACTA NEUROL. SCAND.; DANEM.; DA. 1977; VOL. 56; NO 1; PP. 37-45; BIBL. 1 P. 1/2Article

EFFECTS OF PUTATIVE DOPAMINE AUTORECEPTOR AGONISTS IN PHARMACOLOGICAL MODELS RELATED TO DOPAMINERGIC AND NEUROLEPTIC ACTIVITYARNT J; CHRISTENSEN AV; HYTTEL J et al.1982; EUROPEAN JOURNAL OF PHARMACOLOGY; ISSN 0014-2999; NLD; DA. 1982; VOL. 86; NO 2; PP. 185-198; BIBL. 2 P.Article

GENETIC CONTROL OF DOPAMINE RECEPTORS IN MOUSE CAUDATE NUCLEUS: RELATIONSHIP OF CATALEPTIC RESPONSE TO NEUROLEPTIC DRUGSFINK JS; SWERDLOFF A; REIS DJ et al.1982; NEUROSCI. LETT.; ISSN 0304-3940; NLD; DA. 1982; VOL. 32; NO 3; PP. 301-306; BIBL. 24 REF.Article

Dopamine receptors in brain and periphery: some prospectsCAMSONNE, R.Neurochemistry international. 1987, Vol 10, Num 1, pp 35-37, issn 0197-0186Article

TL333, a benzhydro[G]quinoline, stimulates both D-1 and D-2 dopamine receptors: implications for the selectivity of LY 141865 towards the D-2 receptorITOH, Y; GOLDMAN, M. E; KEBABIAN, J. W et al.European journal of pharmacology. 1985, Vol 108, Num 1, pp 99-101, issn 0014-2999Article